日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs

在注射吸毒人群中实施药剂师、医生和患者导航员协作护理模式(PPP-CCM)治疗丙型肝炎的障碍和促进因素

Austin, Elizabeth J; Gojic, Alexander J; Bhatraju, Elenore P; Pierce, Kathleen A; Pickering, Eleanor I; Tung, Elyse L; Scott, John D; Hansen, Ryan N; Glick, Sara N; Stekler, Joanne D; Connolly, Nancy C; Villafuerte, Sarah; McPadden, Madison; Deutsch, Sarah; Ninburg, Michael; Kubiniec, Robert; Williams, Emily C; Tsui, Judith I

Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study

丙型肝炎治疗启动时间和在门诊使用丁丙诺啡进行阿片类药物治疗的维持时间:一项回顾性队列研究

Geist, Mary L; Radick, Andrea C; Tsui, Judith I; Blalock, Kendra L; Adwell, Addy; Tamru, Elsabeth; Connolly, Nancy C; James, Jocelyn R

Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection

生产一种含有灭活自体病毒的树突状细胞疫苗,用于治疗慢性1型人类免疫缺陷病毒感染患者

Whiteside, Theresa L; Piazza, Paolo; Reiter, Amanda; Stanson, Joanna; Connolly, Nancy C; Rinaldo, Charles R Jr; Riddler, Sharon A

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.

用载有 1 型人类免疫缺陷病毒 (HIV-1) 肽的树突状细胞进行治疗性免疫是安全的,并且能够诱导 HIV-1 感染者的免疫原性

Connolly Nancy C, Whiteside Theresa L, Wilson Cara, Kondragunta Venkatswarlu, Rinaldo Charles R, Riddler Sharon A

CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells

CD27 和 CD57 的表达揭示了人类免疫缺陷病毒 1 型特异性记忆 CD8+ T 细胞的非典型分化

Hoji, Aki; Connolly, Nancy C; Buchanan, William G; Rinaldo, Charles R Jr